文献速递鼻科

慢性鼻窦炎术前诊疗质量评估框架:美国鼻科学会质量改进委员会综述

A framework for quality measurement in the presurgical care of chronic rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-09-03

美国鼻科学会质量改进委员会通过文献综述,将慢性鼻窦炎术前诊疗的关键环节归纳为诊断、药物治疗、手术患者选择及以患者为中心的讨论四类,并构建了CRS Appropriate Presurgical Algorithm(CAPA)框架。该框架提出四项质量指标:基于指南的诊断确认、适当的药物治疗(至少包括局部糖皮质激素和盐水冲洗)、CT扫描以及以患者为中心的讨论。定义这些指标有望减少不必要的实践差异并确保高质量诊疗。

要点

  • 术前应确认基于指南的慢性鼻窦炎诊断。
  • 应尝试适当的药物治疗,至少包括局部糖皮质激素和盐水冲洗(假设患者可耐受)。
  • 应获取CT扫描以确认鼻窦炎症并用于手术规划。

核心结论

  • 定义评估慢性鼻窦炎术前诊疗关键环节的指标,有望进一步改善已有成功的治疗模式、减少不必要的实践差异,并确保患者获得同等水平的高质量诊疗。

研究设计与样本

  • 美国鼻科学会质量改进委员会专家组进行文献综述,将证据整理为诊断、药物治疗、手术患者选择及以患者为中心的讨论四类,并据此构建CAPA框架。

主要发现

  • 在考虑为慢性鼻窦炎提供手术前,最佳可用证据支持以下质量指标:确认基于指南的诊断;尝试适当的药物治疗,至少包括局部糖皮质激素和盐水冲洗(假设患者可耐受);获取CT扫描以确认鼻窦炎症并用于手术规划;进行以患者为中心的讨论,涉及难治性慢性鼻窦炎的治疗选择(替代药物治疗 vs 手术 vs 观察),重点关注风险获益、长期用药依从性的需求以及患者偏好和期望的理解。

关键数值与推荐

  • 术前应确认基于指南的诊断。
  • 应尝试适当的药物治疗,至少包括局部糖皮质激素和盐水冲洗(假设患者可耐受)。
  • 应获取CT扫描以确认鼻窦炎症并用于手术规划。
  • 应进行以患者为中心的讨论,涵盖替代药物治疗 vs 手术 vs 观察的风险获益、长期用药依从性需求及患者偏好和期望。

临床怎么用

  • 在为慢性鼻窦炎患者提供手术前,临床医生应按照CAPA框架评估诊断确认、药物治疗尝试、CT扫描及患者为中心讨论等关键环节,以减少实践差异并确保高质量诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quality improvement (QI) in the management of chronic rhinosinusitis (CRS) is garnering increasing attention. Defining frameworks and metrics to assess the quality of key components in CRS management could assist in reducing unwarranted practice variation and increase high-quality care. METHODS: A panel of the American Rhinologic Society (ARS) QI committee reviewed the literature to determine important presurgical components of CRS care that warrant QI. The evidence was organized into 4 categories: (1) diagnosis, (2) medical management, (3) appropriate patient selection for surgery, and (4) patient-centered discussion. The combination of these categories was used to develop a framework termed the CRS Appropriate Presurgical Algorithm (CAPA). RESULTS: Prior to offering surgery for CRS, the best available evidence support the following quality metrics: (1) a guideline-based diagnosis should be confirmed; (2) appropriate medical management, including a minimum of topical corticosteroid therapy and saline irrigations, should have been attempted (assuming patient tolerance); (3) a computed tomography (CT) scan should be obtained (to confirm the presence of sinus inflammation and for surgical planning); and (4) a patient-centered discussion regarding treatment options for refractory CRS (ie, alternative medical therapies vs surgery vs observation) while focusing on risks and benefits, the need for long-term medical compliance, and understanding of patient preferences and expectations. CONCLUSION: Defining metrics that assess key components to CRS care prior to offering surgery has the potential to further improve upon an already successful treatment paradigm, reduce unwarranted practice variation, and to ensure that patients are receiving a similar level of high-quality care.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Mattos JL, Soler ZM, Rudmik L, et al. A framework for quality measurement in the presurgical care of chronic rhinosinusitis: a review from the Quality Improvement Committee of the American Rhinologic Society. Int Forum Allergy Rhinol. 2018. PMID: 30175899. doi:10.1002/alr.22154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。